NantHealth Inc (NASDAQ:NH) COO Ronald Allen Louks sold 7,095 shares of the stock in a transaction on Tuesday, March 6th. The shares were sold at an average price of $3.56, for a total value of $25,258.20. Following the sale, the chief operating officer now directly owns 89,690 shares in the company, valued at approximately $319,296.40. The sale was disclosed in a document filed with the SEC, which is available at this link.
Ronald Allen Louks also recently made the following trade(s):
- On Tuesday, February 6th, Ronald Allen Louks sold 6,475 shares of NantHealth stock. The shares were sold at an average price of $3.02, for a total value of $19,554.50.
- On Monday, January 8th, Ronald Allen Louks sold 6,175 shares of NantHealth stock. The shares were sold at an average price of $3.52, for a total value of $21,736.00.
NantHealth Inc (NH) traded down $0.10 during trading on Friday, hitting $3.10. The stock had a trading volume of 189,268 shares, compared to its average volume of 89,404. The company has a debt-to-equity ratio of 0.93, a current ratio of 2.38 and a quick ratio of 2.36. The firm has a market cap of $335.99, a PE ratio of -2.08 and a beta of 0.64. NantHealth Inc has a 52-week low of $2.60 and a 52-week high of $6.43.
Institutional investors have recently bought and sold shares of the company. Alliancebernstein L.P. acquired a new stake in shares of NantHealth in the 2nd quarter worth $102,000. Teachers Advisors LLC raised its stake in NantHealth by 351.8% in the 2nd quarter. Teachers Advisors LLC now owns 31,578 shares of the company’s stock worth $134,000 after acquiring an additional 24,588 shares during the last quarter. California State Teachers Retirement System raised its stake in NantHealth by 132.4% in the 2nd quarter. California State Teachers Retirement System now owns 31,600 shares of the company’s stock worth $134,000 after acquiring an additional 18,000 shares during the last quarter. Citadel Advisors LLC purchased a new position in NantHealth in the 4th quarter worth $103,000. Finally, Schwab Charles Investment Management Inc. purchased a new position in NantHealth in the 3rd quarter worth $180,000. 6.27% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: This piece was first posted by BBNS and is the sole property of of BBNS. If you are viewing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright legislation. The original version of this piece can be accessed at https://baseballnewssource.com/2018/03/18/insider-selling-nanthealth-inc-nh-coo-sells-25258-20-in-stock/2009443.html.
NantHealth Company Profile
NantHealth, Inc is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples.
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.